Articles

How do I make sure my retirement accounts go to my wife, and then my kids, when I die?

Planning and proper documentation is required if your wishes are to be carried out

The stock market’s ‘fear gauge’ is trading at lows. Why retail investors should take note.

The  Cboe Volatility Index hasn’t been this low in months.

Tesla’s stock climbs to highest price in years. Here’s why it can keep going.

Tesla’s stock rallies toward a more than 2 1/2-year high, and BofA laid out reasons why it can rise even further.

UnitedHealth’s stock is down 10% this week as exec’s killing leads to criticism of claims treatment

Shares of health insurers and managed-care companies were falling across the board.

I spent months fighting an unfair medical bill. Here’s how I won.

Consumer protections exist, but it can take a lot of time, patience and determination to fight a health insurer, and not everyone prevails.

10 fast-growing software stocks to watch in 2025, including the runaway Palantir

A deeper looks shows that despite the growth, some software stocks have gotten ahead of analysts’ price targets.

What’s in store for the U.S. housing market in 2025?

Also: The aging bull market for stocks, the UnitedHealth aftermath and advice from the Moneyist.

This is the best-performing AI stock this year and it isn’t even close (and it’s not Nvidia)

This company may not have spent as much time in the spotlight as AI chip powerhouse Nvidia, but its stock has soared in 2024.

People think $1 million is the magic number to start estate planning — but it’s much lower

The ideal time to start your estate-planning journey is when you turn 18, experts say — but that’s not what most people do.

Amazon has caught up in the AI race, analysts say, and its stock surges to another record

Amazon’s stock was heading for a third straight record close Friday, as the company’s AWS re:Invent conference gave analysts reason to believe it has caught up with its AI rivals.

OrganiGram purchasing Motif Labs to become Canada’s largest cannabis company by market share, as others retreat

OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.

Ulta Beauty’s stock on track for biggest gain in 2 years. One analyst says it’s still undervalued.

Beauty and cosmetics company’s latest earnings cheered investors and at least 17 analysts hiked stock price targets.
1 64 65 66 67 68 1,821